BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36137662)

  • 1. Imaging Characteristics of CNS Neuroblastoma-
    Tietze A; Mankad K; Lequin MH; Ivarsson L; Mirsky D; Jaju A; Kool M; Hoff KV; Bison B; Löbel U
    AJNR Am J Neuroradiol; 2022 Oct; 43(10):1476-1480. PubMed ID: 36137662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging features of FOXR2-activated CNS neuroblastoma: A case series and systematic review.
    Shimazaki K; Kurokawa R; Franson A; Kurokawa M; Baba A; Bou-Maroun L; Kim J; Moritani T
    J Neuroimaging; 2023; 33(3):359-367. PubMed ID: 36806312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
    von Hoff K; Haberler C; Schmitt-Hoffner F; Schepke E; de Rojas T; Jacobs S; Zapotocky M; Sumerauer D; Perek-Polnik M; Dufour C; van Vuurden D; Slavc I; Gojo J; Pickles JC; Gerber NU; Massimino M; Gil-da-Costa MJ; Garami M; Kumirova E; Sehested A; Scheie D; Cruz O; Moreno L; Cho J; Zeller B; Bovenschen N; Grotzer M; Alderete D; Snuderl M; Zheludkova O; Golanov A; Okonechnikov K; Mynarek M; Juhnke BO; Rutkowski S; Schüller U; Pizer B; von Zezschwitz B; Kwiecien R; Wechsung M; Konietschke F; Hwang EI; Sturm D; Pfister SM; von Deimling A; Rushing EJ; Ryzhova M; Hauser P; Łastowska M; Wesseling P; Giangaspero F; Hawkins C; Figarella-Branger D; Eberhart C; Burger P; Gessi M; Korshunov A; Jacques TS; Capper D; Pietsch T; Kool M
    Neuro Oncol; 2021 Sep; 23(9):1597-1611. PubMed ID: 34077956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas.
    Holsten T; Lubieniecki F; Spohn M; Mynarek M; Bison B; Löbel U; Rutkowski S; Schüller U
    J Neuropathol Exp Neurol; 2021 Jan; 80(1):52-59. PubMed ID: 33270865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background.
    Poh B; Koso H; Momota H; Komori T; Suzuki Y; Yoshida N; Ino Y; Todo T; Watanabe S
    Neuro Oncol; 2019 Aug; 21(8):993-1004. PubMed ID: 30976792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.
    Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H
    Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
    Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
    Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes.
    Łastowska M; Trubicka J; Sobocińska A; Wojtas B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Perek-Polnik M; Dembowska-Bagińska B; Grajkowska W; Matyja E
    Acta Neuropathol Commun; 2020 Jul; 8(1):105. PubMed ID: 32650833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric central nervous system (CNS) neuroblastoma: A case report.
    Sharkey B; Conner KM; McGarvey CR; Nair A; Dorn A; Reinard K; Gabel B
    Surg Neurol Int; 2024; 15():162. PubMed ID: 38840609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonal tumors in the WHO CNS5 classification: A Review.
    Gianno F; Miele E; Antonelli M; Giangaspero F
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion.
    Andreiuolo F; Ferrone CK; Rajan S; Perry A; Guney E; Cham E; Giannini C; Toland A; Willard N; de Souza AS; Dazelle K; Chung HJ; Singh O; Conway K; Coley N; Dampier C; Abdullaev Z; Pratt D; Cimino PJ; Quezado M; Aldape K
    Acta Neuropathol Commun; 2024 Mar; 12(1):42. PubMed ID: 38500181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system neuroblastic tumor with FOXR2 activation presenting both neuronal and glial differentiation: a case report.
    Furuta T; Moritsubo M; Muta H; Koga M; Komaki S; Nakamura H; Morioka M; Ohshima K; Sugita Y
    Brain Tumor Pathol; 2020 Jul; 37(3):100-104. PubMed ID: 32535663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.
    Gojo J; Kjaersgaard M; Zezschwitz BV; Capper D; Tietze A; Kool M; Haberler C; Pizer B; Hoff KV
    Eur J Med Genet; 2023 Jan; 66(1):104660. PubMed ID: 36356895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation.
    Korshunov A; Okonechnikov K; Schmitt-Hoffner F; Ryzhova M; Sahm F; Stichel D; Schrimpf D; Reuss DE; Sievers P; Suwala AK; Kumirova E; Zheludkova O; Golanov A; Jones DTW; Pfister SM; Kool M; von Deimling A
    Acta Neuropathol Commun; 2021 Feb; 9(1):20. PubMed ID: 33536079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
    Cotter JA; Judkins AR
    Pediatr Dev Pathol; 2022; 25(1):34-45. PubMed ID: 35168419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXR2 Stabilizes MYCN Protein and Identifies Non-
    Schmitt-Hoffner F; van Rijn S; Toprak UH; Mauermann M; Rosemann F; Heit-Mondrzyk A; Hübner JM; Camgöz A; Hartlieb S; Pfister SM; Henrich KO; Westermann F; Kool M
    J Clin Oncol; 2021 Oct; 39(29):3217-3228. PubMed ID: 34110923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system (CNS) neuroblastoma. A case-based update.
    Bianchi F; Tamburrini G; Gessi M; Frassanito P; Massimi L; Caldarelli M
    Childs Nerv Syst; 2018 May; 34(5):817-823. PubMed ID: 29520437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes.
    Meyers SP; Khademian ZP; Biegel JA; Chuang SH; Korones DN; Zimmerman RA
    AJNR Am J Neuroradiol; 2006 May; 27(5):962-71. PubMed ID: 16687525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT and Multimodal MR Imaging Features of Embryonal Tumors with Multilayered Rosettes in Children.
    Dangouloff-Ros V; Tauziède-Espariat A; Roux CJ; Levy R; Grévent D; Brunelle F; Gareton A; Puget S; Beccaria K; Blauwblomme T; Grill J; Dufour C; Varlet P; Boddaert N
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):732-736. PubMed ID: 30846437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loco-regional extensions of central nervous system germ cell tumors: a retrospective radiological analysis of 100 patients.
    Duron L; Sadones F; Thiesse P; Cellier C; Alapetite C; Doz F; Frappaz D; Brisse HJ
    Neuroradiology; 2018 Jan; 60(1):27-34. PubMed ID: 28942513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.